Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Tarsounas, M

Class:IdPerson:110865
_displayNameTarsounas, M
_timestamp2004-02-07 12:40:42
firstnameMadalena
initialM
surnameTarsounas
(author)[LiteratureReference:83617] BRCA2-dependent and independent formation of RAD51 nuclear foci.
[LiteratureReference:913240] RAD51 and DMC1 form mixed complexes associated with mouse meiotic chromosome cores and synaptonemal complexes
[LiteratureReference:913754] Expression and nuclear localization of BLM, a chromosome stability protein mutated in Bloom's syndrome, suggest a role in recombination during meiotic prophase
[LiteratureReference:913755] Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I
[LiteratureReference:913860] The time course and chromosomal localization of recombination-related proteins at meiosis in the mouse are compatible with models that can resolve the early DNA-DNA interactions without reciprocal recombination
[LiteratureReference:913863] Protein-protein interactions in the synaptonemal complex
[LiteratureReference:5685830] Role of RAD51C and XRCC3 in genetic recombination and DNA repair
[LiteratureReference:9657197] A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
[LiteratureReference:9943997] Targeting DNA damage response pathways in cancer
[Change default viewing format]
No pathways have been reviewed or authored by Tarsounas, M (110865)